ATE143959T1 - Verfahren und zwischenprodukte für die herstellung von terazosinhydrochloriddehydrat - Google Patents

Verfahren und zwischenprodukte für die herstellung von terazosinhydrochloriddehydrat

Info

Publication number
ATE143959T1
ATE143959T1 AT95103188T AT95103188T ATE143959T1 AT E143959 T1 ATE143959 T1 AT E143959T1 AT 95103188 T AT95103188 T AT 95103188T AT 95103188 T AT95103188 T AT 95103188T AT E143959 T1 ATE143959 T1 AT E143959T1
Authority
AT
Austria
Prior art keywords
tetrahydrofuroyl
dimethoxy
amino
production
quinazolinyl
Prior art date
Application number
AT95103188T
Other languages
English (en)
Inventor
Anthony Mannino
Wayne R Heitmann
Rodger F Henry
Bruce W Horrom
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23264439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE143959(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE143959T1 publication Critical patent/ATE143959T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95103188T 1994-10-18 1995-03-06 Verfahren und zwischenprodukte für die herstellung von terazosinhydrochloriddehydrat ATE143959T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/324,635 US5504207A (en) 1994-10-18 1994-10-18 Process and intermediate for the preparation of terazosin hydrochloride dihydrate

Publications (1)

Publication Number Publication Date
ATE143959T1 true ATE143959T1 (de) 1996-10-15

Family

ID=23264439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95103188T ATE143959T1 (de) 1994-10-18 1995-03-06 Verfahren und zwischenprodukte für die herstellung von terazosinhydrochloriddehydrat

Country Status (11)

Country Link
US (1) US5504207A (de)
EP (1) EP0708104B1 (de)
JP (1) JP2711230B2 (de)
AT (1) ATE143959T1 (de)
BR (1) BR1100705A (de)
CA (1) CA2143971C (de)
DE (1) DE69500064T2 (de)
DK (1) DK0708104T3 (de)
ES (1) ES2089993T3 (de)
GR (2) GR960300047T1 (de)
HK (1) HK130297A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) * 1995-12-13 1997-06-19 Uetikon Chemie Gmbh Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849266B8 (de) * 1996-12-20 2007-10-03 Heumann PCS GmbH Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
US6248888B1 (en) * 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
US20070161791A1 (en) * 2006-01-09 2007-07-12 Narsimha Reddy Penthala Process for the preparation of terazosin hydrocloride dihydrate
AU2007286186A1 (en) * 2006-08-08 2008-02-21 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
AU644895B2 (en) * 1990-08-23 1993-12-23 Dainippon Ink And Chemicals Inc. Antiviral agent
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition

Also Published As

Publication number Publication date
ES2089993T1 (es) 1996-10-16
CA2143971C (en) 1997-06-03
JPH08134066A (ja) 1996-05-28
CA2143971A1 (en) 1996-04-19
EP0708104B1 (de) 1996-10-09
BR1100705A (pt) 1999-10-13
US5504207A (en) 1996-04-02
DK0708104T3 (da) 1997-03-10
GR960300047T1 (en) 1996-08-31
EP0708104A1 (de) 1996-04-24
HK130297A (en) 1997-09-19
JP2711230B2 (ja) 1998-02-10
DE69500064T2 (de) 1997-04-10
DE69500064D1 (de) 1996-11-14
GR3021319T3 (en) 1997-01-31
ES2089993T3 (es) 1997-02-16

Similar Documents

Publication Publication Date Title
ATE143959T1 (de) Verfahren und zwischenprodukte für die herstellung von terazosinhydrochloriddehydrat
ATE456600T1 (de) Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon
WO2003104473A3 (de) Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
ATE315028T1 (de) Herstellungsverfahren für (-)-(2r,4s)-4-((3,5-bis-trifluoromethyl-benzyl) methoxycarbonylamino)-2- ethyl-6-trifluoromethyl-3,4-dihydro-2h-chinolin 1-carbonylsäureethylester
ATE440078T1 (de) Verfahren zur herstellung von alkylaminen
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
ATE520669T1 (de) 1,2-diarylbenzimidazole zur behandlung von erkrankungen die mit einer microglia-aktivierung assoziiert sind
BR0312593A (pt) Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação
ATE461917T1 (de) Verfahren für die herstellung von heterorylaminderivaten
DE59808193D1 (de) Neue vitamin d-derivate mit cyclopropylringen in den seitenketten, verfahren und zwischenprodukte zu ihrer herstellung sowie ihre verwendung zur herstellung von arzneimitteln
ATE250026T1 (de) Verfahren zur herstellung von n-(4,5-bis- methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid
DE60215544D1 (de) Zwischenprodukte für die synthese von lhrh-antagonisten, verfahren zu deren herstellung und verfahren zur herstellung von lhrh-antagonisten
ATE156819T1 (de) Verfahren zur herstellung einer oxazolidincarbon säure nützlich für die herstellung von therapeutischen taxoiden
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
ATE213734T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
EP4324802C0 (de) Mechanochemisch kohlensäurehaltiger ton, verfahren zu seiner herstellung und verwendungen davon
DE602004005175D1 (de) Neues verfahren zur herstellung von 2-aminomethylpyridinderivaten
ATE396178T1 (de) Verfahren zur herstellung von aripiprazol, und entsprechende zwischenprodukte und deren herstellung
ATE372326T1 (de) Verfahren zur herstellung von substituierten 5- amino-n-phenyl-1,2,4-triazol-3-sulfonamiden
DE59803365D1 (de) S-(4-biphenyl)-thioschwefelsäuren und ihre salze, verfahren zu deren herstellung und die herstellung von 4-mercaptobiphenylen
ATE188210T1 (de) Verfahren zur herstellung von prosulfocarb
ATE372994T1 (de) Herstellung von milchsäurederivaten und ihre anwendung
WO2002081442A3 (de) Verfahren zum herstellen von δ1-pyrrolinen
ATE298762T1 (de) Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
ATE432267T1 (de) Verfahren zur herstellung von n-(2,6- dimethylphenyl)-2-piperazin-1-ylacetamid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked